Browsing Tag
Groves Isotope Test Reactor
2 posts
Oklo Q2 2026: $3bn cash backs Aurora-INL as $8.5bn valuation raises execution test
Oklo has accumulated more than $3 billion of cash and marketable securities while advancing its first Aurora powerhouse toward a 2028 deployment target. The balance sheet reduces near-term financing pressure, but only $1.21 million of second-quarter revenue and an $8.5 billion market value leave investors paying primarily for future nuclear execution rather than current operating earnings.
Oklo’s (NYSE: OKLO) Groves isotope reactor enters final pre-startup review after DOE safety approval
Oklo shares have fallen near a 52-week low despite a major Department of Energy approval, shifting attention from regulatory progress to startup execution.